FDA recently approved changes to the EPIVIR (lamivudine) package insert.
The approved changes are detailed here.
FDA approves changes to the Epivir label
01/10/2017
EATG » FDA approves changes to the Epivir label
Newsletter / News bulletin
Latest news
HIV and TB treatment at risk as countries gradually lose Global Fund support
-- Low- and middle-income countries receive donor support for HIV and TB drugs from the Global Fund, but are gradually losing this support -- Global Fund policies on countries that…
Read moreHIV i-Base, HTB: HIVR4P and Glasgow conferences: first reports
HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This issue of HTB includes the first reports from the recent HIV Treatment for Prevention (HIVR4P) and Glasgow…
Read moreViral load in semen rapidly rebounds to infectious levels during HIV treatment breaks
Viral load rebounds rapidly in semen to potentially infectious levels following interruption of combination antiretroviral therapy (cART), according to French research published in AIDS. Increases in viral load in both…
Read moreLatest projects
EFOEUPATI – Ensuring the future of EUPATI beyond 2020
Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for…
PARADIGM – Patients Active in Research and Dialogues for an Improved Generation of Medicines
Project aims: To provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development of medicinal products: (i) the research priority…
HIV Outcomes – Beyond Viral Suppression
Initiative aims: HIV Outcomes, is a multi-stakeholder initiative developing and communicating expert, evidence based consensus recommendations for policy makers focused on the provision and delivery of high quality of care…
